Gastritis

Key Points

  • Gastritis is inflammation of the gastric mucosa and may be acute or chronic, erosive or nonerosive.
  • Acute gastritis is commonly linked to irritants such as NSAIDs/aspirin, alcohol, smoking, infection, or severe stress.
  • Chronic gastritis is often associated with H. pylori infection and can also occur with autoimmune disease, Crohn disease, gastric surgery, or HIV.
  • Untreated gastritis increases risk for peptic ulcer disease, bleeding, perforation, and gastric-cancer progression.
  • Nursing priorities are symptom control, cause-focused education, bleeding surveillance, and adherence to treatment.

Pathophysiology

Gastritis develops when mucosal defense is disrupted and gastric-lining inflammation progresses. In acute patterns, direct irritant injury or stress-related reduction in mucosal bicarbonate protection can produce rapid symptom onset.

In chronic patterns, persistent inflammation is often tied to H. pylori-associated mucosal injury, but autoimmune and inflammatory disease pathways can also contribute. Ongoing untreated inflammation increases risk for ulceration and bleeding complications.

Classification

  • Acute gastritis: Short-course inflammatory pattern often linked to irritants or physiologic stress.
  • Chronic gastritis: Longer-course inflammatory pattern, frequently related to H. pylori or immune-mediated causes.
  • Erosive pattern: Mucosal injury with higher bleeding risk.
  • Nonerosive pattern: Inflammation without major erosive surface injury.

Nursing Assessment

NCLEX Focus

Distinguish uncomplicated dyspeptic symptoms from bleeding or alarm cues needing urgent escalation.

  • Assess acute symptom cues such as epigastric pain, nausea, vomiting, and postprandial upper-abdominal fullness.
  • Recognize that chronic gastritis can be minimally symptomatic or asymptomatic.
  • Assess additional symptom history including belching/hiccups, appetite loss, and blood in stool or emesis.
  • Screen exposure risks including smoking, alcohol use, regular NSAID/aspirin use, and high stress burden.
  • Escalate alarm findings such as GI bleeding, anemia signs, recurrent vomiting, progressive dysphagia/odynophagia, early satiety, and unexplained weight loss.

Diagnostics

  • History-first evaluation: Detailed medical and social history helps separate gastritis from overlapping upper-GI disorders.
  • Endoscopy with biopsy (gold standard): Confirms gastritis pattern and mucosal injury.
  • H. pylori testing: Endoscopy/biopsy-based testing or urease breath testing can confirm infection.
  • Adjunct studies: Upper-GI series may evaluate concurrent reflux, dysphagia, hiatal hernia, ulcer, tumor, or achalasia patterns.
  • Laboratory support: Blood testing can evaluate H. pylori and iron-deficiency anemia from occult GI blood loss; stool testing may detect blood or infectious contributors.

Nursing Interventions

  • Reinforce avoidance of gastric irritants (trigger foods/drinks and ulcerogenic medications when feasible).
  • Support smoking and alcohol cessation counseling.
  • Monitor stool and emesis for bleeding cues and notify the provider immediately for frank blood or black-tarry stool.
  • Track symptom timing, severity, and potential triggers to evaluate treatment response.
  • Reinforce education on treatment adherence and follow-up testing for cause confirmation and eradication plans.
  • Coordinate care plans that include diet modification, stress management, and medication review/deprescribing when indicated.

Pharmacology

Drug ClassRole in Gastritis CareKey Nursing Considerations
proton-pump-inhibitorsAcid suppression and mucosal healing supportReinforce adherence and monitor long-term electrolyte/micronutrient risks when therapy is prolonged.
antibioticsH. pylori eradication when infection is confirmedConfirm regimen completion and follow-up eradication testing plan.
Micronutrient replacementCorrects selected deficiency patternsMatch replacement to documented deficits and trend clinical response.
Immunomodulatory therapySelected autoimmune/inflammatory etiologiesMonitor treatment response and adverse effects in specialty-directed plans.

Clinical Judgment Application

Clinical Scenario

A patient reports epigastric pain, nausea after meals, and intermittent black stools with daily NSAID use.

  • Recognize Cues: Upper-GI pain plus possible melena and high-risk medication exposure.
  • Analyze Cues: Findings suggest gastritis with possible bleeding complication.
  • Prioritize Hypotheses: Immediate priority is bleeding-risk evaluation and cause-directed workup.
  • Generate Solutions: Escalate for diagnostic testing, medication review, and acid-suppression plus eradication planning as indicated.
  • Take Action: Notify provider of bleeding cues, implement monitoring, and reinforce irritant-avoidance education.
  • Evaluate Outcomes: Symptoms and bleeding cues resolve while treatment adherence and trigger reduction improve.